Medical Devices: Page 65
-
Permission granted by Medtronic
Medtronic CEO Martha: No more divestitures planned for 2023, but review continues
“The portfolio review is ongoing,” CEO Geoff Martha said, even as the world's largest medtech company plans to divest dialysis, respiratory interventions and patient monitoring businesses.
By Elise Reuter • Jan. 9, 2023 -
John Moore via Getty Images
Dental medtech market remains steady amid ‘robust’ US employment: Henry Schein
Analysts said the update from company executives is encouraging, although there are potential concerns about pricing.
By Nick Paul Taylor • Jan. 9, 2023 -
Explore the Trendline➔
Sarah Silbiger via Getty Images
TrendlineMedical device safety in spotlight after high profile recalls
From Philips’ massive recall of respiratory devices to ongoing health risks with breast implants, medical devices tied to patient harm have put a focus on product safety.
By MedTech Dive staff -
artJazz via Getty Images
European Commission formalizes plan to extend MDR transition out to 2027, 2028
Having accepted that notified body capacity “remains insufficient,” the Commission wants to give manufacturers more time to get their devices designated under MDR.
By Nick Paul Taylor • Jan. 9, 2023 -
Tim Boyle via Getty Images
Baxter to spin off renal care, acute therapies units
The company is also considering the sale of its Biopharma Solutions business.
By Elise Reuter • Jan. 6, 2023 -
Sarah Silbiger via Getty Images
Vivos bounces back from FDA rejection to land 510(k) clearance for sleep apnea treatment
Shares in Vivos increased by more than 150% on the day of the news.
By Nick Paul Taylor • Jan. 6, 2023 -
Courtesy of GE Healthcare
Q&AFriday Q&A: For GE HealthCare, the future is digital, CEO Arduini says
Digital capabilities will be “the next big inflection” driving growth for GE’s newly independent healthcare business.
By Peter Green • Jan. 6, 2023 -
SciePro via Getty Images
Novocure shares jump on positive lung cancer data
A regimen involving the Swiss biotech’s electrical field-based treatment extended lives in a late-stage trial. But data comparing the medical device to standard chemotherapy is less persuasive.
By Jonathan Gardner • Jan. 5, 2023 -
Courtesy of Embody
Zimmer to acquire soft tissue repair firm Embody for as much as $275M
Buying Embody’s repair system for tendons and ligaments will expand Zimmer Biomet’s share in the growing sports medicine market.
By Elise Reuter • Jan. 5, 2023 -
Peter S Green/MedTech Dive
GE HealthCare starts trading on Nasdaq as independent company
The company’s stock gained in morning trading after debuting at $56 per share.
By Elise Reuter • Jan. 4, 2023 -
Courtesy of Medtronic
‘Mea culpa’: What Goldman Sachs analysts got wrong about Medtronic in 2022
Medtronic has struggled to deliver on key projects in recent years, leading to a decline in its stock performance.
By Nick Paul Taylor • Jan. 4, 2023 -
Retrieved from LinkedIn on January 04, 2023
ReCor names Healthineers exec Barghout as CEO ahead of showdown with Medtronic
ReCor is preparing to go up against Medtronic with its renal denervation system, in a market that the latter expects to grow to $3 billion by the end of the decade.
By Nick Paul Taylor • Jan. 4, 2023 -
Courtesy of AliveCor
Apple infringed on AliveCor wearable patents, ITC says in final ruling; import ban suspended
The commission found that Apple has infringed on two AliveCor patents and thereby violated a law that can trigger an import ban.
By Nick Paul Taylor • Jan. 4, 2023 -
ryasick via Getty Images
Deep DiveA look back at medtech’s top 10 acquisitions of 2022
While larger acquisitions were announced at the end of the year including J&J’s $16.6B purchase of Abiomed, the number of deals declined from 2021.
By Elise Reuter • Dec. 22, 2022 -
Mario Tama via Getty Images
J&J closes acquisition of heart pump maker Abiomed
The $16.6 billion purchase was the largest medtech transaction of 2022.
By Elise Reuter • Dec. 22, 2022 -
Courtesy of Philips
Philips’ studies argue recalled DreamStation CPAP machines unlikely to harm patients’ health
In a briefing on testing of the machines, Philips said exposure to degraded foam used to soundproof the devices is unlikely to harm patients.
By Elise Reuter • Dec. 21, 2022 -
Brendan Hoffman via Getty Images
Diagnostic testing reform missing from Congress’ year-end spending bill
A provision that would have brought in-vitro diagnostic tests and lab-developed tests under one regulatory framework was not included in the omnibus spending bill.
By Elise Reuter • Dec. 21, 2022 -
Courtesy of Odin Vision
Olympus agrees to $80M takeover of artificial intelligence endoscopy startup Odin Vision
The acquisition gives Olympus control of cloud-based AI systems to help detect and characterize cancerous and precancerous tissues during colonoscopies and gastroscopies.
By Nick Paul Taylor • Dec. 21, 2022 -
Pixelseffect via Getty Images
As diabetes technology advances, blood glucose control declines: study
Mexican-American and non-Hispanic Black adults saw the greatest drop as the proportion of patients with glycemic control fell from 29.2% between 1988 and 1994 to 27.5% between 2013 and 2020.
By Nick Paul Taylor • Dec. 21, 2022 -
Courtesy of Medtronic
Medtronic starts US robotic surgery trial in push to challenge Intuitive
Medtronic delayed the Hugo program to make changes in light of surgeon feedback, but now plans to evaluate the use of the surgical robot in urologic procedures, facing off against competitor Intuitive.
By Nick Paul Taylor • Dec. 20, 2022 -
titoOnz via Getty Images
MDR costs are driving manufacturers to pull products from European market: report
The report adds to evidence that makers of products used for pediatric patients and rare diseases have been particularly hard hit.
By Nick Paul Taylor • Dec. 20, 2022 -
Popovaphoto via Getty Images
Fraud risk increased among Medicare DME suppliers who enrolled under pandemic waivers: GAO
Of 208 providers that had their Medicare enrollment revoked between 2020 and 2022, 83% were durable medical equipment suppliers, according to a report from the Government Accountability Office.
By Elise Reuter • Dec. 19, 2022 -
J&J subsidiaries accuse former Auris employees of stealing robotic surgery trade secrets
The lawsuit claims former Auris employees engaged in “shameless, systematic and ongoing misappropriation of trade secrets.”
By Nick Paul Taylor • Dec. 19, 2022 -
Prostock-Studio via Getty Images
Click wins FDA breakthrough designation for prescription digital migraine therapy
The designation would give Click Therapeutics expedited review of its preventive treatment for episodic migraine in adults.
By Nick Paul Taylor • Dec. 19, 2022 -
Courtesy of Synchron
Gates, Bezos invest in Synchron’s brain computer interface
A $75 million investment will accelerate the development of a drill-free implant to help patients with upper-limb paralysis.
By Peter Green • Dec. 16, 2022 -
Siemens, GE Healthcare are interested in Medtronic spinoff units: Bloomberg
Medtronic said in October it plans to divest its patient monitoring and respiratory interventions businesses.
By Elise Reuter • Dec. 15, 2022
Previous
